Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 23/11/20051 min de lecture
Investigational New Drugs: Export Requirements for Unapproved New Drug Products
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is amending its regulations on the exportation of investigational new drugs, including biological products. The final rule describes four different mechanisms for exporting an investigational new drug product. These provisions implement changes in FDA's export authority resulting from the FDA Export Reform and Enhancement Act of 1996 and also simplify the existing requirements for exports of investigational new drugs.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →